4 Midcap Profit CAGR 15-25 Per Cent Stocks to Watch for Future Multibagger Potential: Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies
- October 28, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Aditya Birla Capital Rs 353.55. Radico Khaitan Rs 4,290. Narayana Health Rs 1,713.20. Endurance Technologies Rs 2,278.30. Market caps from Rs 32,537 crore to Rs 99,071 crore. Data as of 27 Oct 2026.
Quick Answer
Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies are the 4 picks in this profit CAGR 15-25 per cent stocks watchlist, with market caps between Rs 32,537 crore and Rs 99,071 crore. Aditya Birla Capital stands out for the lowest PE of the group at 24.06, while Radico Khaitan offers the highest return on equity at 18.23%. PE ratios run from 24.06 to 85.71, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.
Profit CAGR 15-25 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies meet that test, with market caps from Rs 32,537 crore to Rs 99,071 crore and Aditya Birla Capital offering the lowest PE of the group at 24.06. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a four-year net profit CAGR between 15 and 25 per cent from FY22 to FY26, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a four-year net profit CAGR between 15 and 25 per cent from FY22 to FY26, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening profit CAGR 15-25 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Profit CAGR 15-25 Per Cent Stocks and Why Do They Attract Multibagger Interest?
Profit CAGR 15-25 per cent stocks are shares of mid sized companies whose net profit compounded at 15 to 25 per cent a year between FY22 and FY26, a long run of steady earnings growth. The four here cover financial services, spirits, hospitals and auto components.
Four years of double digit profit growth shows a business that earns more every year, which is the habit that creates long term wealth. Within profit CAGR 15-25 per cent stocks, the four companies show rising profit. For profit CAGR 15-25 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read profit CAGR 15-25 per cent stocks, the common thread is rising profit backed by complete financial data. With profit CAGR 15-25 per cent stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for profit CAGR 15-25 per cent stocks are complete. Read each company’s latest results and exchange filings before acting on profit CAGR 15-25 per cent stocks.
Profit CAGR 15-25 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 27 October 2026. Aditya Birla Capital has the lowest PE of the group at 24.06, while Radico Khaitan posts the highest return on equity at 18.23%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Aditya Birla Capital | 353.55 | 99,071 | 24.06 | 17.68 | 10.96% | 2.58 | 287.70 to 430.70 |
| Radico Khaitan | 4,290 | 60,304 | 85.71 | 54.95 | 18.23% | 18.19 | 2,500.00 to 4,747.00 |
| Narayana Hrudayalaya | 1,713.20 | 34,664 | 42.44 | 60.75 | 17.76% | 7.64 | 1,589.00 to 2,093.30 |
| Endurance Technologies | 2,278.30 | 32,537 | 33.55 | 37.33 | 13.91% | 4.76 | 2,142.80 to 3,072.00 |
Aditya Birla Capital: 23.52% Profit CAGR Since FY22
Aditya Birla Capital is the financial services arm of the Aditya Birla Group, with lending, asset management, insurance and wealth businesses. It reported FY26 total income of Rs 45,617.39 crore, up 12.02% year on year, and net profit of Rs 3,863.80 crore, up 14.25%. Net profit has compounded at 23.52% a year since FY22, while total income has grown 19.67% a year.
In the June 2026 quarter, total income rose 27.87% to Rs 12,187.05 crore and net profit grew 43.25% to Rs 1,223.85 crore. The share price has gained 251.61% over five years and 25.70% over the past year. Domestic institutions raised their holding from 12.06% in June 2025 to 13.48% in June 2026. The stock trades at a PE of 24.06 against an industry PE of 17.68.
Radico Khaitan: 24.88% Profit CAGR Since FY22
Radico Khaitan makes Indian-made foreign liquor and premium spirits, with brands including Magic Moments, 8PM and Rampur Single Malt. It reported FY26 revenue of Rs 6,062.27 crore, up 24.84% year on year, and net profit of Rs 604.48 crore, up 74.90%. Net profit has compounded at 24.88% a year since FY22, while revenue has grown 20.50% a year. Operating margin was 4.88% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.
The stock trades at a PE of 85.71 against an industry PE of 54.95, with a return on equity of 18.23%. In the June 2026 quarter, revenue rose 10.44% to Rs 5,869.46 crore and net profit grew 75.91% to Rs 229.60 crore. The share price has gained 299.58% over five years and 51.47% over the past year. Domestic institutions raised their holding from 25.47% in September 2025 to 27.17% in September 2026.
Narayana Health: 24.06% Profit CAGR Since FY22
Narayana Health runs a network of multi-speciality hospitals, with a strong cardiac care franchise and a presence in India and the Cayman Islands. It reported FY26 revenue of Rs 7,996.25 crore, up 43.43% year on year, and net profit of Rs 810.46 crore, up 2.61%. Net profit has compounded at 24.06% a year since FY22, while revenue has grown 20.95% a year. Operating margin was 21.25% in FY26.
In the June 2026 quarter, revenue rose 77.60% to Rs 2,719.11 crore and net profit grew 5.37% to Rs 207.27 crore. The share price has gained 225.59% over five years. Domestic institutions raised their holding from 7.76% in September 2025 to 10.68% in September 2026. The stock trades at a PE of 42.44 against an industry PE of 60.75, below the sector average, with a return on equity of 17.76%.
Endurance Technologies: Revenue Up 26.05% in FY26
Endurance Technologies makes suspension, braking, transmission and aluminium casting products for two-wheelers, three-wheelers and cars. It reported FY26 revenue of Rs 14,719.85 crore, up 26.05% year on year, and net profit of Rs 951.71 crore, up 13.79%. Net profit has compounded at 19.89% a year since FY22, while revenue has grown 18.01% a year. Operating margin was 14.17% in FY26. The debt-to-equity ratio is 0.19.
The stock trades at a PE of 33.55 against an industry PE of 37.33, below the sector average, with a return on equity of 13.91%. In the June 2026 quarter, revenue rose 29.62% to Rs 4,348.28 crore and net profit grew 8.03% to Rs 244.52 crore. Domestic institutions raised their holding from 9.06% in September 2025 to 10.48% in September 2026.
Profit CAGR 15-25 Per Cent Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these profit CAGR 15-25 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Aditya Birla Capital | 45,617.39 | 3,863.80 | 12.02% | 19.67% | 23.52% |
| Radico Khaitan | 6,062.27 | 604.48 | 24.84% | 20.50% | 24.88% |
| Narayana Health | 7,996.25 | 810.46 | 43.43% | 20.95% | 24.06% |
| Endurance Technologies | 14,719.85 | 951.71 | 26.05% | 18.01% | 19.89% |
Check the Univest Screener for live data on these profit CAGR 15-25 per cent stocks
Institutional Holding in Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies
Institutional holding shows who is backing these profit CAGR 15-25 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Radico Khaitan has the deepest institutional backing, with FII and DII together holding 46.60% as of September 2026. Domestic institutions increased their holding over the past year in Aditya Birla Capital (from 12.06% to 13.48%), Radico Khaitan (from 25.47% to 27.17%), Narayana Health (from 7.76% to 10.68%) and Endurance Technologies (from 9.06% to 10.48%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Aditya Birla Capital | 68.81% | 8.60% | 13.48% | 9.12% | June 2026 |
| Radico Khaitan | 40.17% | 19.43% | 27.17% | 13.23% | September 2026 |
| Narayana Health | 63.27% | 9.01% | 10.68% | 17.04% | September 2026 |
| Endurance Technologies | 75.00% | 12.07% | 10.48% | 2.45% | September 2026 |
Risks to Weigh in Profit CAGR 15-25 Per Cent Stocks
Being careful with profit CAGR 15-25 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Radico Khaitan trades at a PE of 85.71 against an industry PE of 54.95, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Profit CAGR 15-25 Per Cent Stocks
Picking from profit CAGR 15-25 per cent stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (17.68 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies live prices.
Conclusion
Among profit CAGR 15-25 per cent stocks, Aditya Birla Capital stands out for the lowest PE of the group at 24.06, Radico Khaitan for the highest return on equity at 18.23%, Narayana Health for 43.43% revenue growth in FY26 and Endurance Technologies for 26.05% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing profit CAGR 15-25 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Profit CAGR 15-25 Per Cent Stocks to Watch
Which are the best profit CAGR 15-25 per cent stocks to watch for multibagger potential?
Ans. Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies are the 4 names this list highlights, with market caps of Rs 99,071 crore, Rs 60,304 crore, Rs 34,664 crore and Rs 32,537 crore respectively. Aditya Birla Capital is notable for the lowest PE of the group at 24.06. Radico Khaitan stands out for the highest return on equity at 18.23%. Narayana Health offers 43.43% revenue growth in FY26. Endurance Technologies brings 26.05% revenue growth in FY26. These are watchlist names for profit CAGR 15-25 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Radico Khaitan a good stock for long-term investors?
Ans. Radico Khaitan has a return on equity of 18.23%, a PE of 85.71 against an industry PE of 54.95 and a market cap of Rs 60,304 crore. Net profit has compounded at 24.88% a year since FY22, and FY26 revenue rose 24.84% while June 2026 quarter net profit grew 75.91%. Long-term returns in profit CAGR 15-25 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Narayana Health become a multibagger from here?
Ans. Narayana Health has already gained 225.59% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in profit CAGR 15-25 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 24.06% a year since FY22, and FY26 revenue rose 43.43%. At a PE of 42.44 against an industry PE of 60.75, valuation should be checked against that growth before investing.
What is the market cap of Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies?
Ans. As of 27 October 2026, Aditya Birla Capital has a market cap of Rs 99,071 crore, Radico Khaitan has a market cap of Rs 60,304 crore, Narayana Health has a market cap of Rs 34,664 crore and Endurance Technologies has a market cap of Rs 32,537 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on profit CAGR 15-25 per cent stocks.
What are the risks of investing in profit CAGR 15-25 per cent stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Radico Khaitan trades at a PE of 85.71 against an industry PE of 54.95, so earnings growth needs to hold up.
Why is Radico Khaitan trading at a PE of 85.71?
Ans. Radico Khaitan’s PE of 85.71 compares with an industry PE of 54.95. The market is paying a premium for a return on equity of 18.23%, profit growth of 24.88% a year since FY22 and latest-quarter profit growth of 75.91%, which also means the stock is more sensitive if growth slows. Investors in profit CAGR 15-25 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Aditya Birla Capital, Radico Khaitan, Narayana Health and Endurance Technologies?
Ans. As of the latest reported quarter, FII and DII together hold 22.08% of Aditya Birla Capital (8.60% and 13.48%), 46.60% of Radico Khaitan (19.43% and 27.17%), 19.69% of Narayana Health (9.01% and 10.68%) and 22.55% of Endurance Technologies (12.07% and 10.48%). Rising institutional holding is a useful signal in profit CAGR 15-25 per cent stocks, though it should be read with earnings trends rather than on its own.
